Year |
Citation |
Score |
2015 |
Muhamadali H, Xu Y, Morra R, Trivedi DK, Rattray NJ, Dixon N, Goodacre R. Metabolomic analysis of riboswitch containing E. coli recombinant expression system. Molecular Biosystems. PMID 26621574 DOI: 10.1039/c5mb00624d |
0.44 |
|
2015 |
Morra R, Shankar J, Robinson CJ, Halliwell S, Butler L, Upton M, Hay S, Micklefield J, Dixon N. Dual transcriptional-translational cascade permits cellular level tuneable expression control. Nucleic Acids Research. PMID 26405200 DOI: 10.1093/nar/gkv912 |
0.44 |
|
2015 |
Wu MC, Lowe PT, Robinson CJ, Vincent HA, Dixon N, Leigh J, Micklefield J. Rational Re-engineering of a Transcriptional Silencing PreQ1 Riboswitch. Journal of the American Chemical Society. PMID 26106809 DOI: 10.1021/jacs.5b03405 |
0.44 |
|
2014 |
Vincent HA, Robinson CJ, Wu MC, Dixon N, Micklefield J. Generation of orthogonally selective bacterial riboswitches by targeted mutagenesis and in vivo screening. Methods in Molecular Biology (Clifton, N.J.). 1111: 107-29. PMID 24549615 DOI: 10.1007/978-1-62703-755-6_8 |
0.44 |
|
2012 |
Chen L, Cressina E, Dixon N, Erixon K, Agyei-Owusu K, Micklefield J, Smith AG, Abell C, Leeper FJ. Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues. Organic & Biomolecular Chemistry. 10: 5924-31. PMID 22514012 DOI: 10.1039/c2ob07116a |
0.44 |
|
2012 |
Dixon N, Robinson CJ, Geerlings T, Duncan JN, Drummond SP, Micklefield J. Orthogonal riboswitches for tuneable coexpression in bacteria. Angewandte Chemie (International Ed. in English). 51: 3620-4. PMID 22383398 DOI: 10.1002/anie.201109106 |
0.44 |
|
2011 |
Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, Nowak DG, Dixon N, Micklefield J, Spannhoff A, Bedford MT, Gregory MA, Martin CJ, Leadlay PF, Zhang MQ, Harper SJ, et al. Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science (Royal Society of Chemistry : 2010). 2011: 273-278. PMID 22822423 DOI: 10.1039/C0SC00297F |
0.44 |
|
2011 |
Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D, Ahel I. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature. 477: 616-20. PMID 21892188 DOI: 10.1038/nature10404 |
0.44 |
|
2010 |
Dixon N, Duncan JN, Geerlings T, Dunstan MS, McCarthy JE, Leys D, Micklefield J. Reengineering orthogonally selective riboswitches. Proceedings of the National Academy of Sciences of the United States of America. 107: 2830-5. PMID 20133756 DOI: 10.1073/pnas.0911209107 |
0.44 |
|
2008 |
Kóta Z, Páli T, Dixon N, Kee TP, Harrison MA, Findlay JB, Finbow ME, Marsh D. Incorporation of transmembrane peptides from the vacuolar H(+)-ATPase in phospholipid membranes: spin-label electron paramagnetic resonance and polarized infrared spectroscopy. Biochemistry. 47: 3937-49. PMID 18307317 DOI: 10.1021/bi7025112 |
0.44 |
|
2008 |
Dixon N, Páli T, Kee TP, Ball S, Harrison MA, Findlay JB, Nyman J, Väänänen K, Finbow ME, Marsh D. Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophysical Journal. 94: 506-14. PMID 17872954 DOI: 10.1529/biophysj.107.111781 |
0.44 |
|
2007 |
Dixon N, Wong LS, Geerlings TH, Micklefield J. Cellular targets of natural products. Natural Product Reports. 24: 1288-310. PMID 18033580 DOI: 10.1039/b616808f |
0.44 |
|
2006 |
Fernandes F, Loura LM, Fedorov A, Dixon N, Kee TP, Prieto M, Hemminga MA. Binding assays of inhibitors towards selected V-ATPase domains. Biochimica Et Biophysica Acta. 1758: 1777-86. PMID 16996024 DOI: 10.1016/j.bbamem.2006.07.006 |
0.44 |
|
2006 |
Fernandes F, Loura L, Koehorst RB, Dixon N, Kee TP, Hemminga MA, Prieto M. Interaction of the indole class of vacuolar H(+)-ATPase inhibitors with lipid bilayers. Biochemistry. 45: 5271-9. PMID 16618115 DOI: 10.1021/bi0522753 |
0.44 |
|
2005 |
Whyteside G, Meek PJ, Ball SK, Dixon N, Finbow ME, Kee TP, Findlay JB, Harrison MA. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain. Biochemistry. 44: 15024-31. PMID 16274249 DOI: 10.1021/bi051529h |
0.44 |
|
2004 |
Dixon N, Páli T, Kee TP, Marsh D. Spin-labelled vacuolar-ATPase inhibitors in lipid membranes. Biochimica Et Biophysica Acta. 1665: 177-83. PMID 15471583 DOI: 10.1016/j.bbamem.2004.08.001 |
0.44 |
|
2004 |
Páli T, Whyteside G, Dixon N, Kee TP, Ball S, Harrison MA, Findlay JB, Finbow ME, Marsh D. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector. Biochemistry. 43: 12297-305. PMID 15379568 DOI: 10.1021/bi0493867 |
0.44 |
|
2004 |
Páli T, Dixon N, Kee TP, Marsh D. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies. Biochimica Et Biophysica Acta. 1663: 14-8. PMID 15157605 DOI: 10.1016/j.bbamem.2004.03.003 |
0.44 |
|
2003 |
Dixon N, Pali T, Ball S, Harrison MA, Marsh D, Findlay JB, Kee TP. New biophysical probes for structure-activity analyses of vacuolar-H+ -ATPase enzymes. Organic & Biomolecular Chemistry. 1: 4361-3. PMID 14685305 DOI: 10.1039/b311401e |
0.44 |
|
2001 |
Pulacchini S, Shastri K, Dixon NC, Watkinson M. A remarkably efficient and direct route for the synthesis of binucleating 1,4,7-triazacyclononane ligands Synthesis. 2381-2383. |
0.44 |
|
2001 |
Kee T, Dixon N. Living dangerously Chemistry in Britain. 37: 38-41. |
0.44 |
|
Show low-probability matches. |